In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Advocacy Bulletin

A regular update on ESC Advocacy

ESC Advocacy will provide regular updates on its initiatives via an e-newsletter. Past editions can be found below.



Advocacy Bulletin - March 2019

Welcome to the first Advocacy Bulletin  

Lina-Badimon.v3.jpgAdvocacy is a fundamental pillar of the ESC Strategic Plan. The aim of ESC Advocacy is to leverage the knowledge and influence of the cardiology profession to promote policy and regulation favourable to cardiovascular health. Advocacy is a fundamental pillar of the ESC Strategic Plan. The aim of ESC Advocacy is to leverage the knowledge and influence of the cardiology profession to promote policy and regulation favourable to cardiovascular health.  

But do you know the many initiatives we have launched? Over the coming year, we will provide you with periodic updates in the form of this Advocacy Bulletin. We hope you will take a moment to learn about what we do, and perhaps be inspired to join us in this exciting effort.

Professor Lina Badimon

Chair, ESC Advocacy Committee 2018-2020

 

Advocating for cardiovascular research


ERA-CVD Logo.v3.jpgThe burden of CVD is substantially bigger than the societal cost related to other diseases, yet CVD research funding lags well behind research funding in other clinical areas, notably cancer. The burden of CVD is substantially bigger than the societal cost related to other diseases, yet CVD research funding lags well behind research funding in other clinical areas, notably cancer.  

To address this unbalance the ESC has worked closely with the ERA-CVD network to develop an advocacy document, titled “Strategic Research Agenda for CVD in Europe”. We will share the document with you next month, when finalised, hoping that you can help us raise awareness of the importance of continuous and increased investment in cardiovascular research with decision-makers in your country.  

 

Mobilising National Cardiac Societies in Advocacy  Mobilising National Cardiac Societies in Advocacy


ESC Spring summit 2019-285 600x300.jpgDuring the 2019 ESC Spring Summit, the Chair of the ESC Advocacy Committee met with leaders of a number of National Cardiac Societies (NCS) to discuss how the ESC and NCS can join forces to advocate for cardiovascular health. During the 2019 ESC Spring Summit, the Chair of the ESC Advocacy Committee met with leaders of a number of National Cardiac Societies (NCS) to discuss how the ESC and NCS can join forces to advocate for cardiovascular health.

There was consensus that CVD is no longer perceived as a priority by decision-makers and that urgent and bold action is needed to bring CVD high on the agenda of policymakers. ESC Advocacy will establish a CardioPolicy Group as the mechanism to engage NCS in advocacy. We hope you will join!  

 

ESC Atlas of Cardiology: the power of data to advocate for policy change


ESC Atlas Infographics_Pacemakers.jpgTo demonstrate the need for policy action, ESC Advocacy has used ESC Atlas of Cardiology data to produce a series of infographics. To demonstrate the need for policy action, ESC Advocacy has used ESC Atlas of Cardiology data to produce a series of infographics. The series, "Cardiovascular Realities in Europe", reveals wide geographic disparities and social inequalities. We will continue to use Atlas data to raise cardiovascular health on the policy agenda. More information here.

 

Open Access to publications: ESC advocating for flexibility


cOAlitionS_Visual-1.v4.jpgThe European Commission, together with a group of national research funders, are pushing for open access publishing of all research results they fund by 2020.  The European Commission, together with a group of national research funders, are pushing for open access publishing of all research results they fund by 2020.  

This move is expected to have significant implications for learned societies that manage and publish academic journals. ESC Advocacy is working with the BioMed Alliance in Europe - representing 30 European medical societies - to press for a longer transition period in order to mitigate implications and ensure a successful transition to open access. Read here the position statement.  

 

Understanding the regulatory framework applicable to remote monitoring of cardiac implanted devices


TF_remote_monitoring_CIEDs.v3.jpg Analysing the policy and regulatory environment to assess challenges and opportunities is an integral part of advocacy. A joint Task Force established by the ESC Regulatory Affairs Committee (which is part of Advocacy) and EHRA met in Brussels on 27-28 February 2019 to evaluate how the new EU General Data Protection Regulation applies to cardiac implanted electronic devices. The Task Force also evaluated the legal implications that exist for patients and clinicians regarding data produced from remote monitoring. Preliminary findings were discussed in a dedicated (and crowded!) session at the EHRA Congress. The final recommendations will be presented at the ESC Congress 2019 in Paris.

 

EU funding opportunities for CVD research


EU Calls.v2.jpegInterested in learning more about EU funding opportunities for your research project? Click here for direct access to current available calls. All calls are set out in annual work programmes, which are regularly updated. The revised work programme for Horizon 2020 will be published in June 2019, including new calls with deadlines for autumn 2019. Possible topics of interest include new therapies for non-communicable diseases and healthcare interventions for the management of elderly multimorbid patients. For more information, you can contact Christina Dimopoulou